[Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging]
- PMID: 16827985
- DOI: 10.1157/13090655
[Dementia with Lewy bodies and Alzheimer's disease: differential diagnosis by cardiac sympathetic innervation MIBG imaging]
Abstract
Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease (AD). At present, pre-mortem diagnosis of DLB can only be made clinically using the International Consensus Criteria. However, an accurate differential diagnosis between these diseases could improve the therapeutic handling of patients with DLB, due to their supersensitivity to neuroleptic treatment and the difficult treatment of their psychotic symptoms.
Objective: To assess the utility of cardiac MIBG imaging as diagnostic study for DLB, to help in the differential diagnosis with AD.
Material and methods: Cardiac MIBG imaging was performed in 11 patients with clinical criteria of probable DLB (7 males, mean age 77 years [range 62-89 years], mean MMSE 17 [range 11-28], and in 9 patients with clinical criteria of probable AD (3 males, mean age 79 years [range 61-87 years], mean MMSE 17 [range 4-25]). Planar anterior images of the thorax were acquired at 15 minutes. (early study) and 4 hours (late study) after tracer injection. Myocardial MIBG activity was quantified by means of a heart-to-mediastinum ratio (HMR). A HMR > 1.8 was considered normal.
Results: Respect AD patients, patients with DLB showed decreased HMR in the early study (1.34 +/- 0.27 [range 1.03-1.98] vs. 1.84 +/- 0.22 [range 1.53-2.15], p<0.001) and in the late study (1.22 +/- 0.23 [range 0.95-1.75] vs. 1.73 +/- 0.08 [range 1.59-1.89], p<0.0001).
Conclusions: Cardiac MIBG imaging could be a useful tool for differential diagnosis between DLB and AD.
Similar articles
-
[Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia].Rev Esp Med Nucl Imagen Mol. 2013 Mar;32(2):77-80. doi: 10.1016/j.remn.2012.03.012. Epub 2012 May 18. Rev Esp Med Nucl Imagen Mol. 2013. PMID: 23177334 Spanish.
-
(123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.J Neurol Sci. 2015 Oct 15;357(1-2):173-7. doi: 10.1016/j.jns.2015.07.025. Epub 2015 Jul 17. J Neurol Sci. 2015. PMID: 26208800
-
Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.PLoS One. 2015 Mar 20;10(3):e0120540. doi: 10.1371/journal.pone.0120540. eCollection 2015. PLoS One. 2015. PMID: 25793585 Free PMC article.
-
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11. Rinsho Shinkeigaku. 2008. PMID: 18386627 Review. Japanese.
-
Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.Curr Radiopharm. 2014;7(1):75-8. doi: 10.2174/1874471007666140314094323. Curr Radiopharm. 2014. PMID: 24635146 Review.
Cited by
-
Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer's disease.PLoS One. 2009 Jun 24;4(6):e6033. doi: 10.1371/journal.pone.0006033. PLoS One. 2009. PMID: 19551139 Free PMC article.
-
Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life.Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1636-41. doi: 10.1007/s00259-008-0828-8. Epub 2008 May 29. Eur J Nucl Med Mol Imaging. 2008. PMID: 18509631
-
Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1139-46. doi: 10.1007/s00259-011-1754-8. Epub 2011 Mar 4. Eur J Nucl Med Mol Imaging. 2011. PMID: 21373765
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical